Upload
ashutoshsharma
View
217
Download
0
Embed Size (px)
Citation preview
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 1/17
1
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
Comparative studies of Cevac IBD L and some
of its main competitors
Results
C. Cazaban
International Technical Manager
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 2/17
2
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
Stud !o." #D$%&"'%(&&)* +. ,orgach- safet and serolog response
in S/, birds
10-day old SPF birds.
Ocular vaccination with
• Nobilis 228E (co!"titor 1#$ or
• %& (co!"titor 2#$
•'"vac &) *.
+0 birds !"r ,rou! (incl. control ,rou!#
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 3/17
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
Kinetics of virus replication in the bursa of Fabricius in 10-day oldSPF birds (study no.1)
0
1
2
3
!
"
2 3 # 1! 21
$ays of the study
% u r s a
h i s t o l o & y s c o r e ( ' u
r P h )
opetitor 1 opetitor 2 evac *%$ + ontrols
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 4/17
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
%,% inde in 10-day old SPF birds on $2 (study no.1)
0
0/1
0/2
0/3
0/
0/!
0/"
0/#
%% inde
opetitor 1 opetitor 2 evac *%$ +
*nterediate
ot
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 5/17
/
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
Serolo&y curve in 10-day old SPF birds (study no.1)
0123
!"#
10111213
0 # 1! 21 2
$ays of the study
* %
$ t i t r e ( i n l o &
2 )
opetitor 1 opetitor 2 evac *%$ + ontrols
*
*
*: statistical di fference
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 6/17
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 7/17
7
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
Stud !o.( Immunosuppression stud #D$0&"10(&&)* $. /ala-
11-day old SPF birds. /0 birds !"r ,rou!.
Ocular vaccination ()ay 0# with
• Nobilis 228E (co!"titor 1#$• %& (co!"titor 2#$
• Poulvac &ursa Plus (co!"titor #$
• &) &l"n (co!"titor #$ or
• '"vac &) *.
Ocular vaccination with '"vac ni * day .
N) chall"n," (9"rts strain$ 10+ E)/0 !"r bird$ by i# day 18.
N) chall"n," ass"ss"nt day 2.
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 8/17
:
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
%,% inde in 11-day old SPF birds on $32 (study no.2)
0
0/1
0/2
0/3
0/
0/!
0/"
0/#
%% indeopetitor 1 opetitor 2 opetitor 3 opetitor evac *%$ +
*nterediate
ot
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 9/17
10
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
*%$ Serolo&y curve in 11-day old SPF birds (study no.2)
0
1
23
!
"
#
10
11
12
13
0 1 32
$ays of the study
* % $ t i t r e ( i n l o &
2 )
opetitor 1 opetitor 2 opetitor 3 opetitor evac *%$ + ontrols
*
*
*: statistical di fference
*%$ vaccination
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 10/17
11
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
$ Serolo&y curve in 11-day old SPF birds
0
1
2
3
!
"
#
0 1 32
$ays of the study
$ 0 * t i t r e ( i n l o & 2 )
op 1 4 5ni + op 2 4 5ni + op 3 4 5ni + op 4 5ni + evac *%$ + 4 5ni + evac 5ni + ontrols
*
*: statistical difference
*%$ vaccination $ vaccination
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 11/17
12
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
$ challen&e in 11-day old SPF birds100 100 100 100 100 100
0
0
10
20
30
0
!0
"0
#0
0
0
100
P r o t e c t i o n r a t e ( 6 )
op 1 4 5ni + op 2 4 5ni + op 3 4 5ni + op 4 5ni + evac *%$ + 4 5ni + evac 5ni + SPF controls
$0, *%$ vaccination
$, $ vaccination
$1, $ challen&e
$32, $ challen&e
assessent
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 12/17
1
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
7ise in * titre follo8in& $ challen&e in 11-day old SPF birds
0
0/!
1
1/!
2
2/!
3
3/!
$ 3 2 t i t r e i n c h a l l e n & e d -
$ 3 2 t i t r e i n u n c h a l l e n & e d
b i r d s
op 1 4 5ni + op 2 4 5ni + op 3 4 5ni + op 4 5ni + evac *%$ + 4 5ni + evac 5ni +
$0, *%$ vaccination
$, $ vaccination
$1, $ challen&e
$32, $ challen&e assessent
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 13/17
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 14/17
1/
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
Stud !o.) #D$%()0(&&) $. /ala- safet and efficac in commercialbroilers
'o"rcial broil"rs$ ocularly vaccinat"d at 17 days o a," (%); <N
titr" hatch 12.8$ and 17 d : lo,2# with (12/ birds !"r ,rou!3 1+/
controls#• Nobilis 228E (co!"titor 1#
• ;bic %& (co!"titor 2#
• Poulvac &ursa Plus (co!"titor #
• &) &l"n (co!"titor #
• '"vac &) *
vv&) chall"n,"$ %O9: strain$ 10 E)/0 !"r bird (20 birds !"r ,rou!#$
oral rout".
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 15/17
1+
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
evac *%$ + in broilers, coparison to copetitors, &ro8th
0
!00
1000
1!00
2000
2!00
3000
1 21 2 3! 2
9&e of the chic:ens (days)
9 v e r a & e b o d y 8 e i &
h t ( & )
opetitor 1 opetitor 2 opetitor 3 opetitor evac *%$ + ontrol
accination at 1# days
of a&e
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 16/17
17
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
evac *%$ + in broilers, coparison to copetitors, vv*%$ challen&eresults
0
10
20
30
0
!0
"0
#0
0
0
100
1st challen&e ($2) 2nd challen&e ($32)
irus replication in the bursa days after challen&e
' t e n t o f b u r s
a
i n v o l v e e n t i n 6 )
opetitor 1 opetitor 2 opetitor 3 opetitor evac *%$ + ontrol
7/23/2019 i Bd Compar Compet Trials
http://slidepdf.com/reader/full/i-bd-compar-compet-trials 17/17
1:
Cevac IBD L comparison to competitorsCevac IBD L comparison to competitors
%ain conclusions
• '"vac &) * is sa" on th" ,rowth o th" co"rcial broil"rs.
• Followin, th" "arli"st chall"n," (7 days !-v$ birds a,"d 2 days#$
'"vac &) * (and &) &l"n# !rot"ct"d th" bursa3 228E$ %&$ or
Poulvac &ursa Plus did not.
• Followin, th" lat" chall"n," (1/ days !-v$ birds a,"d 2 days#$
'"vac &) * (and %& and Poulvac &ursa Plus# !rot"ct"d a,ainstilln"ss$ as "vid"nc"d by th" body w"i,ht ,ain3 &) &l"n or 228E
did not. ;ll vaccin"s siilarly !rot"ct"d th" bursa.